MARKET VECTORS ETF TR - BIOTECH ETF (BBH)

CUSIP: 57060U183

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / BIOTECH ETF
Total 13F shares
1,250,109
Share change
-372,886
Total reported value
$119,231,120
Put/Call ratio
49%
Price per share
$95.38
Number of holders
58
Value change
-$34,715,522
Number of buys
25
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 57060U183?
CUSIP 57060U183 identifies BBH - MARKET VECTORS ETF TR - BIOTECH ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - BIOTECH ETF (BBH) as of Q2 2014

As of 30 Jun 2014, MARKET VECTORS ETF TR - BIOTECH ETF (BBH) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,250,109 shares. The largest 10 holders included CREDIT SUISSE AG/, UBS AG, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, MURPHY CAPITAL MANAGEMENT INC, HOKANSON ASSOCIATES, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, Eagle Capital Management, LLC, and LPL Financial LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.